116.50 -0.13 (-0.11%)
Pre-Market: 6:26AM EDT
|Bid||116.20 x 1000|
|Ask||116.70 x 900|
|Day's Range||116.55 - 117.64|
|52 Week Range||84.86 - 125.36|
|Beta (3Y Monthly)||0.35|
|PE Ratio (TTM)||81.56|
|Earnings Date||Oct 22, 2019|
|Forward Dividend & Yield||2.98 (2.54%)|
|1y Target Est||124.00|
Analysts identified their 11 highest-conviction names going into this earnings season, with positive catalysts over the next two months that they predict will send shares higher.
Procter & Gamble Co. has launched an advertising campaign featuring social media stars Mila and Emma Stauffer, 4-year-old twins who tout a new product.
(ULVR)—the maker of Dove and TRESemmé—is going head to head with Pantene owner Procter & Gamble cutting prices in the U.S. as it aims to gain market share. Hair has been a key battleground for consumer-products makers, with shampoo offering healthy profit margins and opportunities to innovate by adding minor ingredients. “There’s been a very vibrant and competitive battle in hair care in North America,” said Unilever (ticker: UL PLC) Chief Financial Officer Graeme Pitkethly.
Procter & Gamble Co. has launched an internship program for experienced professionals – especially women – who might have put a pause on their careers to raise children or care for an aging or ailing family member. The intent is to hire them for management positions.
Procter & Gamble was up 27.9% YTD on October 16, outperforming the broader markets by a wide margin. PG plans to announce its Q1 earnings on October 22.
During the fast-paced Lightning Round of Jim Cramer's Mad Money program Wednesday night, one caller asked about Procter & Gamble : "That's a pretty good stock and I like it at this level," said Cramer. In this daily bar chart of PG, below, we can see a strong uptrend the past 12 months. The daily On-Balance-Volume (OBV) line shows only a slight decline in recent weeks so we should not worry that investors have become aggressive sellers.
On CNBC's "Mad Money Lightning Round," Jim Cramer said Canopy Growth Corp (NYSE: CGC ) needs new CEO for the stock to trade higher. Constellation Brands (NYSE: STZ ) needs to buy more stock or ...
If the story of Britain’s high street is one of inexorable decline, then the paperback will be on sale at WHSmith. Paying $400m for gift shop group Marshall brings 170 new US outlets — 59 in airports — lifting WHSmith to third place in the $3bn US airport retail market. To retail analysts, the Marshall deal read particularly well.
Procter & Gamble Co. has been issued a patent for a method of formulating a skin-lightening composition, which could be used in cosmetics designed for people who have skin damaged by sunlight, disease, hormones or aging.
From Vicks, the #1 Selling Children's Brand for Cough & Cold1, Vicks Children’s Cough & Congestion Offers Fast and Effective Symptom Relief Without Extra Stuff They Don’t N
Efforts to boost productivity, improved pricing and marketing initiatives may have aided Consumer Staples companies in the September quarter, while high costs and macro factors are likely to have hurt.
A palm oil industry watchdog will adopt rules next month that will impose fines on consumer goods companies like Unilever and Nestle if they don't start buying more green palm oil to help curb deforestation in Southeast Asia, the regulating body said. Producers of palm oil, a commodity used in everything from ice cream to lipstick, are blamed for destroying millions of hectares of forest in Southeast Asia, in part by using slash-and-burn techniques that blanketed Singapore, Malaysia and Indonesia in smog in September.
There's something to be said about following the "smart money's" lead into adventurous, high-potential growth plays. But billionaires also see plenty of potential in stable blue chips like the Dow Jones Industrial Average's components. Indeed, Dow stocks make up considerable portions of some high-profile managers' portfolios.Billionaire investors often are viewed as more sophisticated, better informed and more likely to enter what would be considered more esoteric trades than the average investor. In some cases, those assumptions are true.But there's something to be said about safety, as well as the ability of some well-known large-cap stocks to deliver surprisingly outsize returns. Big-time money managers know that - and have put their money where their brains are.Investors of every ilk would be wise to take the hint and consider following that lead.Here are seven Dow stocks that make up a large chunk of at least one billionaire investor's holdings. We'll examine how much they hold, as well as which qualities each billionaire investor likely appreciates most about their pick. SEE ALSO: All 30 Dow Stocks Ranked: The Analysts Weigh In
Procter & Gamble Co. CEO David Taylor has agreed to chair United Way of Greater Cincinnati’s multimillion-dollar fundraising campaign next year.
Procter & Gamble’s effort to add people with autism to the workforce has resulted in the hiring of managers to work at the company’s global headquarters in Cincinnati.
Boom and bust cycles can easily last a few years. A classic case is the dot-com cycle, when lasted from 1998 to 2000, giving investors time to snag juicy returns.But cannabis stocks have been different. Their boom-bust cycle only lasted a year or so. And it is far from clear if marijuana stocks have bottomed.Source: Shutterstock The silver lining is that the valuations of marijuana stocks have become much more attractive, while their growth outlook appears to be intact.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Hot Stocks Staging Huge Reversals There are a variety of high-quality marijuana stocks that investors can consider buying. But let's take a look at one: Aurora Cannabis (NYSE:ACB).Granted, the chart of ACB stock is downright scary. During the past year, Aurora Cannabis stock has gone from $12 to $3.77.While the valuation of ACB stock is still far from cheap, its growth remains particularly strong. Ultimately, that should lead to higher margins and profits, which will make Aurora stock more attractive. The Pros of ACB StockAurora has operations across 25 countries on five continents. Besides a thriving consumer business, ACB also has an extensive medical operation, as it employs more than 40 highly educated researchers, and has conducted a long list of clinical trials and case studies. What's more, the company is making a big play for the CBD-based wellness category, which is likely to become a multi-billion dollar business in the US. The Cons of ACB StockIt's true that ACB stock is facing a great deal of risk. The Canadian cannabis market has been beset with difficulties, as its supply chain has been problematic and it's been hurt by the continuing strength of the black market. Additionally, Hexo's (NYSE:HEXO) negative earnings preannouncement was a sign that the cannabis sector's growth may be decelerating.Moreover, vaping may have caused a number of deaths. While the ultimate cause of the deaths is unclear, they have damaged the cannabis industry's image. The Bottom Line on Aurora Cannabis StockAll in all, these are serious problems, and it will take some time to deal with them. But then again, Wall Street has been factoring all this into ACB stock. So even a small amount of good news could easily spark a rally by Aurora stock.But it's important to keep in mind that there are some potential catalysts that can help get ACB stock back on track. One is Cannabis 2.0. This refers to the legalization of CBD edibles, topicals and beverages in Canada. According to Deloitte, those products could generate $2.7 billion of revenue.Next, ACB has a top-notch strategic advisor, the legendary Nelson Peltz. He runs an activist investment fund and has taken positions in companies like Procter & Gamble (NYSE:PG), Mondelez (NASDAQ:MDLZ), and Wendy's (NASDAQ:WEN). No doubt, he'll be able to leverage his own network to identify strategic partners and investors.Granted, despite all this, ACB stock will likely remain volatile. So it's probably best to refrain from buying too many shares of Aurora stock initially. But in the long-term, ACB does look like it has what it takes to be a winner.Tom Taulli is the author of the book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Hot Stocks Staging Huge Reversals * 7 Under-The-Radar Growth Stocks That Could Benefit New Investors * 5 Excellent High-Yield Dividend Stocks to Buy The post Aurora Cannabis Stock: It's Not Time to Throw in the Towel appeared first on InvestorPlace.
Ericsson's (ERIC) third-quarter results are supported by commercial 5G contract wins in 19 customer networks across 15 countries, spanning four continents.
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What are the poorest cities in America in 2019? The United States is popular for its opulence and the unimaginable success of its people. Around seven out of the ten richest people in the world are American. These people live in metropolitan areas with the best performing economies in the world. Nonetheless, this is not the […]